Crossmark

The outcome of patients with inflammatory bowel disease–associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer–a matched-pair analysis of survival

Crossref DOI link: https://doi.org/10.1007/s00384-021-04072-9

Published Online: 2021-12-04

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vitali, Francesco https://orcid.org/0000-0002-1867-6602
Wein, Axel

Rath, Timo https://orcid.org/0000-0002-7728-9338
Eckstein, Markus

Neufert, Clemens https://orcid.org/0000-0002-0502-391X
Siebler, Jürgen https://orcid.org/0000-0002-1745-408X
Atreya, Raja https://orcid.org/0000-0002-8556-8433
Hartmann, Arndt

Hohenberger, Werner

Weber, Klaus

Neurath, Markus Friedrich https://orcid.org/0000-0003-4344-1474
Grützmann, Robert

Merkel, Susanne https://orcid.org/0000-0003-2676-9486
Funding

Funding for this research was provided by:

Universitätsklinikum Erlangen
License Information

Text and Data Mining valid from 2021-12-04

Version of Record valid from 2021-12-04
More Information

Article History

Accepted: 22 November 2021

First Online: 4 December 2021

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below